[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@WallStSai Avatar @WallStSai S A I ™️

S A I ™️ posts on X about $xbi, $vktx, $abvx, $lly the most. They currently have XXXXX followers and XX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence stocks XXXXX% finance XXXXX% currencies XXXXX% cryptocurrencies XXXX% travel destinations XXXX%

Social topic influence $xbi #3, $vktx #3, $abvx #14, $lly #10, $nvo #13, $gpcr #1, eli lilly #11, $azn #9, $mrk #56, xbi #2

Top accounts mentioned or mentioned by @bioinvestor24 @askfinvest @pjamess69 @stockgutter @andre_agtc @troytiger @aggregategains @pacha_8x @doodaddoctor @seekingalpha @doepkemichel @maziardoustdar @researchpulse1 @pharmdca @bavariaron @tbbtrades @mroliverbarnes @amaymd @doctorsalomon @adamfeuerstein

Top assets mentioned Bitcoin Incognito (XBI) Viking Therapeutics, Inc (VKTX) Eli Lilly and Company (LLY) Novo-Nordisk (NVO) AstraZeneca PLC (AZN) Merck & Co., Inc. (MRK) AltLayer (ALT) AbbVie Inc (ABBV) Pfizer, Inc. (PFE) Viking Holdings Ltd (VIK) Bristol-Myers Squibb Co (BMY) Metsera, Inc. Common Stock (MTSR) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Gilead Sciences, Inc. (GILD) Cidara Therapeutics, Inc. (CDTX) Synthetify (SNY) Intra-Cellular Therapies Inc. (ITCI) The Official XX Coin (67) Goldman Sachs (GS)

Top Social Posts

Top posts by engagements in the last XX hours

"Looks like $ABVX not presenting at JPM"
X Link 2025-12-09T23:31Z 7795 followers, 11.1K engagements

"$ALT ALTIMMUNE CEO TO STEP DOWN EFFECTIVE JAN X PEMVIDUTIDE 48WK MASH DATA DUE Q4 2025"
X Link 2025-12-01T13:33Z 7794 followers, 1509 engagements

"@bioinvestor24 @maziardoustdar $ABBV may partner with $VKTX for VK2809 as well who knows 🤷🏻♂"
X Link 2025-12-03T19:52Z 7794 followers, XXX engagements

"@ResearchPulse1 @Pharmdca It wont be an issue. $PFE put in pressure using political influence on FTC. $NVO will not have any issues acquiring $VKTX as it has got multiple items in their pipeline like MASH and XAD as well apart from GLP1. Why only buyout Why not partnerships"
X Link 2025-12-03T21:49Z 7794 followers, XXX engagements

"$VKTX There is that squeeze Flow speaks. Buyout Rumors"
X Link 2025-12-04T15:20Z 7791 followers, 26.1K engagements

"Did $NVO CEO see this 🤨 $VKTX"
X Link 2025-12-04T15:45Z 7794 followers, 6705 engagements

"$MDGL Mardi Dier CFO of Madrigal Pharmaceuticals spotlights the company's latest quarter and the launch of their first product. She talks about Madrigal's drug sales the company's balance sheet international expansion and an extended patent. $XBI"
X Link 2025-12-04T22:43Z 7773 followers, 3349 engagements

"Looks like $GPCR GLP-1 data release is imminent on monday. Lots of options positioning today. $XBI $VKTX $LLY $NVO"
X Link 2025-12-05T16:23Z 7792 followers, 14.5K engagements

"$GPCR GLP-1 36wk ph2b $ALT MASH 48wk ph2 $XBI data on deck next week possibly which ones will succeed/fail Also M&A weekend time Bring those deal rumors back on Lot of M&A firepower with big pharma especially $BMY $AZN $GILD $MRK $PFE"
X Link 2025-12-05T20:01Z 7791 followers, 4601 engagements

"@bioinvestor24 They better drop out their drug and buy $VKTX instead 😜"
X Link 2025-12-06T02:41Z 7772 followers, XXX engagements

"$XBI This bidding process clearly shows how desperate big pharma is right now to replace LOEs and Patent Expirations. If you put away $MRK there are still five different big pharma companies who participated in a bid to acquire $CDTX. They all should have decent M&A fire power and may acquire other smaller biotech companies down the line in a short timeframe. Just recently biotech sector witnessed bidding war between $PFE and $NVO to acquire $MTSR The annual J.P. Morgan Healthcare Conference (JPM) served as a powerful catalyst for Mergers and Acquisitions (M&A) activity in the biotech sector"
X Link 2025-12-06T03:11Z 7778 followers, 6338 engagements

"$ABVX Who will it be $AZN or $SNY"
X Link 2025-12-08T20:19Z 7793 followers, 5263 engagements

"$AZN Aggresive Dec19 XXXX puts bought into close $ABVX M&A deal on cards"
X Link 2025-12-08T20:37Z 7793 followers, 8861 engagements

"@mroliverbarnes Brother I certainly assume FT biotech M&A scoop is already in works 😀 European company and hope you are on top of the coverage 👍🏼 $ABVX $AZN"
X Link 2025-12-08T23:43Z 7794 followers, 4826 engagements

"@bioinvestor24 $ITCI also presented at JPM this year but got bought out just a day before JPM conference has started. So no big deal we can get acquired anytime. $MDGL is my hot favorite for buyout now"
X Link 2025-12-10T00:23Z 7794 followers, XXX engagements

"@A_May_MD Adam - You are absolutely right You have a very valid point. Who will just throw away $4M in OTM options calls that too $XX away current stock price strikes that too just one week to expiration Very obvious its a buyout positioning just before the deal gets announced"
X Link 2025-12-10T00:57Z 7792 followers, XXX engagements

"$MRK $XBI MERCK LOOKS TO RAISE UP TO $X BILLION FROM US DOLLAR BOND SALE"
X Link 2025-12-01T14:48Z 7793 followers, 7706 engagements

"$BMY Bristol Myers must face $XXX billion lawsuit over delayed cancer drug US judge rules Bristol Myers accused of delaying FDA approvals for three drugs Lawsuit linked to $XXXX billion Celgene acquisition"
X Link 2025-12-02T03:26Z 7794 followers, 42.3K engagements

"$XBI Why $NVO Novo Nordisk may look to acquire $VKTX Viking Therapeutics $NVO Novo is aggressively pursuing M&A after losing the $MTSR Metsera bid and needs a dual-agonist to compete with $LLY Eli Lilly 🔹 Dual Agonism (GLP-1/GIP) $NVO Novo Nordisk's current successful drugs (Wegovy Ozempic) are single GLP-1 agonists. $VKTX Viking's VK2735 is a dual GLP-1/GIP agonist the same mechanism as Eli Lilly's Zepbound/Mounjaro which has shown highly competitive efficacy data. Acquiring $VKTX would immediately provide $NVO Novo Nordisk with a powerful next-generation dual-action molecule to compete"
X Link 2025-12-03T06:39Z 7795 followers, 46K engagements

"$ABBV Abbvie CFO says they will continue to look for M&A transactions in obesity space and they are not finished with Gubra transaction $XBI $VKTX $LLY $NVO $GPCR"
X Link 2025-12-03T17:01Z 7795 followers, 9303 engagements

"$ALT MASH data release looks imminent this week"
X Link 2025-12-08T19:38Z 7794 followers, 2383 engagements

"@adamfeuerstein So should we wait till Goldman Sachs conference for buyout 😜"
X Link 2025-12-10T01:29Z 7795 followers, 1182 engagements

"$CDTX Big Options flow detected on 11/10 and Buyout deal announced 11/14. Unusual Flow always knows $ABVX Options flow is also in the same boat. With no catalysts events presentations and data who would buy deep OTM calls worth $4M expiring in one week"
X Link 2025-12-10T01:47Z 7795 followers, 6485 engagements

"$ABVX CEO Marc de Garidel is good at making M&A deals he led two biotech deals below. At the same time he worked for $LLY Eli Lilly as well 🔹 Sale of CinCor Pharma to AstraZeneca. 🔹 Sale of Corvidia Therapeutics to Novo Nordisk"
X Link 2025-12-10T04:08Z 7795 followers, 7788 engagements

"$ABVX ABIVAX POPS XX% ON MARKET TALK ABOUT $LLY ELI LILLY TAKEOVER INTEREST - REUTERS Two traders citing market speculation about potential takeover interest from Eli Lilly. Abivax and Eli Lilly were not immediately available for comment"
X Link 2025-12-10T10:07Z 7795 followers, 7822 engagements

"$LLY ELI LILLY'S TRIPLE AGONIST RETATRUTIDE DELIVERED WEIGHT LOSS OF UP TO AN AVERAGE OF XXXX LBS ALONG WITH SUBSTANTIAL RELIEF FROM OSTEOARTHRITIS PAIN IN FIRST SUCCESSFUL PHASE X TRIAL $XBI $NVO $GPCR $VKTX $ABBV"
X Link 2025-12-11T11:51Z 7795 followers, 8621 engagements